Tuesday, September 22

Healthcare

Lisata jumps on FDA orphan drug status for liver cancer drug

09/07/20241 Min Read

cancer drug FDA jumps Lisata liver orphan status

Previous ArticleAscendis raised to outperform by Oppenheimer ahead of drug launch

Next Article Eli Lilly bets $409M for AI-focused drug discovery